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Improving knowledge of and access to 
reproductive health technologies is criti-
cal to improving women’s health. While 
major gains have been made over the 
past several decades, barriers to access 
remain in many places of the world. Con-
traceptive technologies that enhance 
women’s ability to exercise control over 
their reproductive lives are particularly 
important; emergency contraception is 
one such example.  
Emergency contraception (EC) has been in use 
for more than 30 years, is available in many 
countries, exists in multiple formulations, and is 
offered through a range of service delivery points. 
EC is an effective and safe method of preventing 
pregnancy, and its provision of postcoital protec-
tion gives it a unique role in the contraceptive mix 
within family planning programs. 
 
Currently, three types of emergency contracep-
tion exist: (1) dedicated emergency contraceptive 
pill (ECP) products, including levonorgestrel-only 
pills and ulipristal acetate; (2) conventional oral 
contraceptive pills taken in a specific timing and 
dosage sequence (known as the Yuzpe method); 
and (3) the insertion of a copper intrauterine de-
vice (IUD).  The IUD has not been used to any 
extent as EC in the developing world at this point. 
BACKGROUND 
Dedicated ECP products are registered in coun-
tries throughout the world, and many countries 
have more than one registered ECP product. More 
than 60 countries provide ECP through pharma-
cies. The Yuzpe method is used in settings where 
no dedicated ECP products are available, and/or 
where economic and service barriers prohibit 
women from obtaining them. Although this type of 
off-label use of oral contraceptives is an important 
option for women, a dedicated product—one that 
is packaged and labeled specifically for emergency 
contraceptive use and made available through a 
range of outlets (clinics, pharmacies, hospitals, 
women’s shelters, workplaces)—could potentially 
improve access and use. In theory ECP is widely 
available; in practice, however, procurement, fi-
nancing, and distribution mechanisms for dedicat-
ed ECP commodities are not well established in 
many settings, thereby limiting availability and 
resulting in an underutilized option for pregnancy 
prevention.  
BARRIERS TO ACCESS FOR WOMEN: POLI-
CIES, PROVIDERS, AND HEALTH SYSTEMS  
Research indicates a number of influences on 
women’s access to ECP. Access is most severely 
affected in countries where contextual and sys-
tems-level barriers converge to restrict provision 
and use of ECP. The following barriers have been 
noted across diverse settings: (1) lack of favorable 
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and providers; (3) undefined and inadequate service 
delivery systems; and (4) stringent prescription require-
ments. Further, awareness of emergency contraception 
and the sources of supply for ECP is limited among  
potential users.  
Role of providers and key opinion leaders  
Although women’s access to ECP is constrained by many 
factors, providers and key opinion leaders (KOLs) play a 
key role in ensuring its availability and enhancing access 
to the product. Providers’ lack of accurate information 
and training in ECP, coupled with negative attitudes and 
misconceptions about the method, directly affect their 
provision practices and, in turn, women’s access. Key 
opinion leaders, who include a range of influential indi-
viduals (e.g., senior Ministry of Health officials, leaders of 
medical and pharmacy associations, civil society repre-
sentatives, religious and other social leaders, donors, 
etc.), also play a critical role in shaping public opinion 
and influencing policy.  
 
WIDENING THE LENS AND DEEPENING THE FOCUS 
ON PROVIDERS AND KEY OPINION LEADERS  
Recognizing the critical role these two stakeholder 
groups play in fostering or impeding access, the Popu-
lation Council conducted a cross-sectional, descriptive, 
multicountry study in India, Nigeria, and Senegal 
aimed at understanding the attitudes, beliefs, and 
practices of providers and key opinion leaders regard-
ing the provision and use of EC. This study represents 
the first systematic inquiry of KOLs in these three 
countries, which have considerably different social and 
policy environments. 
India 
In India, ECP is included in the National Family Planning 
Program and, theoretically, is available at government 
health and family planning facilities. Because many doc-
tors and paramedics have not been trained, however, 
uptake is low, particularly in rural areas. The product is 
available over the counter, and has been aggressively 
promoted in urban areas. Although the MOHFW officially 
supports universal access to ECP, in practice it has not 
taken action to support this policy. At the state level, 
knowledge about ECP is uniformly poor and negative.  
Nigeria 
Although modern methods of contraception and emer-
gency contraceptives are available over the counter, use 
of modern contraceptive methods, including ECP, re-
mains low in Nigeria. The main access point for users of 
modern contraceptives is the private sector (61 percent), 
compared with 23 percent in the public sector. Patent 
 
  
medicine vendors and local pharmacists constitute 39 
percent and 10 percent, respectively, of the private 
sources. Younger unmarried women tend to patronize 
the private sector, whereas older married women typi-
cally obtain products through the public sector.  
Senegal 
In Senegal, ECP is included in the national family plan-
ning program and, in principle, is available for free at 
public sector facilities. In practice, however, clients pur-
chase ECP at pharmacies at higher prices. ECP provi-
sion in the public sector is hampered by a weak health 
system characterized by poor services, poorly trained 
providers, intermittent commodity supplies, and poor 
recordkeeping and data monitoring.  
 
STUDY OBJECTIVE 
The overarching goal of this study was to investigate 
and document providers’ attitudes, beliefs, and practic-
es regarding ECP, and to capture the opinions and in-
sights of providers and KOLs on a range of policy and 
program issues. In addition, the study sought to experi-




A mix of quantitative and qualitative methods was used. 
Through a quantitative survey applied to a representa-
tive sample of service providers in each country, the 
study gathered information on providers’ attitudes to-
ward ECP use and users, their level of knowledge and 
training, their opinions regarding repeat use, and their 
ECP provision practices. ―Provider‖ was broadly defined 
to include frontline health workers, midwives, nurses, 
doctors, pharmacists, patent medicine vendors, and 
other health staff. Qualitative data gathered through in-
depth interviews with selected KOLs were combined 
with provider surveys to give a robust and nuanced pic-
ture of the current situation regarding provision of ECP. 
Site and sample selection 
The study was designed to align with broader urban 
health initiatives currently underway in each country; 
thus, urban centers were selected for sampling. The 
study was conducted in a total of ten urban centers: five 
in India (Agra, Aligarh, Delhi, Kanpur, and Lucknow), two 
in Nigeria (Abuja and Kaduna), and three in Senegal 
(Dakar, Mbour, and Thies).  
Using existing sampling frames in each country, a rep-
resentative sample of providers was drawn from each 
country. The analysis includes only providers who were 
currently or had ever provided ECP. 
TABLE 1    Number of interviews conducted, by provider type, 
according to country 
Provider type India  Nigeria Senegal  Total  
Doctors 83 21   10 114 
Paramedics  33 0 0 33 
Nurse/midwife 0 118   85 203 
Pharmacists 199 146   26 371 
Pharmacy counter staff 0 0   30 30 
Patent medicine vendors   0 122 0 122 
Others  0 0    4 4 
Total  315 407 155 877 
 
Sixty-six in-depth interviews were conducted across the 
three countries with purposively sampled KOLs from 
both the public and private sectors. The interviews cap-
ture multiple perspectives that reflect policy, program, 
service delivery, and civil society positions.  
 
TABLE 2    Number of interviews, by type of KOL, according to 
country 
Profile of  
key opinion leaders India  Nigeria  Senegal Total 
Government officials/ 
decisionmakers at policy 
and program levels 
8 4 11 23 
Members of professional 
associations  
7 5 5 17 
NGO representatives 0 3 3 6 
Development part-
ners/donors   
3 1            4 8 
Manufacturer 1 0 0 1 
Private practitioner 0 0 1 1 
Distributors  0 0 3 3 
Members of community-
based organizations 
0 0 7 7 
Total  19 13 34 66 
 
FINDINGS  
Each country has unique and specific findings which are 
reported elsewhere (see India, Nigeria, and Senegal 
briefs). Here we describe overall study results. Although 
the three countries have vastly different social and politi-
cal contexts, and are at different stages in the evolution of 
ECP programming and maturity of family planning pro-
grams, the following key themes emerged across sites:  
 
 Gaps exist in providers’ knowledge of technical issues, 
including mechanisms of action, efficacy, and timing of 
use. 
 Wide variation across and within countries exists in 
levels of training on ECP among different cadres of 
providers.  
 KOLs hold positive views of ECP overall, believing it 
fills an important niche in the contraceptive method 
mix.   
 
  
 Providers’ attitudes are mixed concerning provision 
of ECP to particular populations (e.g., young unmar-
ried women) and in certain contexts. 
 Providers and KOLs are generally not supportive of 
―advance provision‖ of ECP, because of the underly-
ing assumption that this leads to ―abuse‖ or ―over 
use‖; they express concern that women will bypass 
or abandon ―regular contraception‖ if  ECP provision 
is lenient.   
 The majority of providers are unsupportive of ―repeat 
use‖ and/or ―regular use.‖ 
 Interpretations and definitions of ―repeat use,‖ ―regu-
lar use,‖ and ―frequent use‖ vary widely; most provid-
ers are unable to provide a precise definition.   
 KOLs express some caveats about how and where 
ECP should be distributed, who should provide it, 
and for which target populations.   
 
As shown in Table 3, the vast majority of providers in 
the three countries (86–94 percent) consider ECP to 
be safe, and the majority (60–82 percent) believes  
 
TABLE 3    Percentage of providers expressing various atti-
tudes and beliefs concerning ECP  
ECP attitude/belief India Nigeria Senegal 
Safety    
ECP is safe to use 86 94 88 
Efficacy    
ECP is very effective in preventing 
pregnancy 
82 66 60 
Access    
Women should be provided with 
ECP in advance of unprotected sex 
55 67 17 
ECP should be available OTC with-
out prescription 
50 33 41 
There should be no age  
restriction on ECP 
14 14 45 
Frequency of use    
There is no maximum number of 
times a women can use EC in one 
year  
64 23 39 
In one menstrual cycle, EC can be 
used after unprotected sex as 
needed 
15 18 16 
There should be guidance/ 
advice on the frequency of EC 
provision for women 
44 90 83 
Acceptable contexts for use    
Rape or sexual coercion 15 50 93 
Infrequent or unpredictable sex 55 20 81 
Unprotected sex  23 49 88 
Refugee or conflict settings 3 55 54 
Acceptable users    
Married women 67 12 53 
Unmarried adolescents 42 14 65 
N (315) (407) (155) 
that it is effective in preventing pregnancies. With regard 
to more specific access issues—advance provision, age 
restrictions, frequency of use—responses become more 
conservative, and also vary more widely across the three 
countries. The concept of ―repeat use‖ is one such divi-
sive issue, in part, perhaps, because of the lack of stan-
dardization regarding what is meant by the term. For 
some providers, the threshold for ―repeat use‖ is two or 
three times per menstrual cycle, whereas for others it is 
one or two times per year. 
 
PROGRAM AND POLICY IMPLICATIONS 
The identification and amelioration of provider-related 
barriers is a critical avenue to improve EC access within 
country programs and globally. Many provider-related 
barriers can be overcome through implementation of 
targeted interventions such as training and values clari-
fication, whereas other barriers will require a broader 
strategy to address contextual and health systems-level 
factors that hinder women’s access to ECP.  
 
Interventions that might prove useful in addressing 
these barriers include:  
 Improving knowledge about ECP among provid-
ers and potential users through a variety of 
channels, including digital and electronic  
communication, mass media, public aware- 
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ness campaigns, and educational print ma-
terials for providers and potential users. 
 Evidence-based advocacy targeted to poli-
cymakers and donors to garner commitment   
to both the concept of emergency contracep-
tion as well as ECP products, including their 
integration into family planning programs, 
processes, and budgets. 
 Efforts to reduce the cost of EC products and 
product delivery. This may include bulk pur-
chasing of commodities, greater competition 
in the marketplace (with new post coital  
contraceptive products), and/or negotiation 
with manufacturers and distributors regard-
ing pricing strategies. 
 Operational research on a range of service 
delivery issues, including bridging ECP with 
other family planning methods. 
 Social science research to better understand 
the social determinants of demand and use 
dynamics. 
 
 Support for research and development for 
post-coital prevention products. 
For more information, contact 
mbrady@popcouncil.org. 
 
 
 
